Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Asp Julia 1973 ) "

Sökning: WFRF:(Asp Julia 1973 )

  • Resultat 1-10 av 38
  • [1]234Nästa
Sortera/gruppera träfflistan
  • Asp, Julia, 1973-, et al. (författare)
  • CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.
  • 2006
  • Ingår i: Genes, chromosomes & cancer. - 1045-2257. ; 45:9, s. 820-8
  • Tidskriftsartikel (refereegranskat)abstract
    • Pleomorphic salivary gland adenomas are characterized by recurrent chromosome rearrangements of 8q12, leading to activation of the PLAG1 oncogene. Here we demonstrate that CHCHD7-PLAG1 is a novel and recurrent gene fusion generated by a cytogenetically cryptic rearrangement in pleomorphic adenomas. CHCHD7 is a newly identified member of a multifamily of proteins containing a conserved (coiled coil 1)-(helix 1)-(coiled coil 2)-(helix 2) domain. Northern blot analysis revealed that the gene is ubiquitously expressed. Its biological function is unknown and the gene has hitherto not been associated with neoplasia. CHCHD7 and PLAG1 are located head-to-head about 500 bp apart in 8q12. Molecular analyses of 27 tumors revealed CHCHD7-PLAG1 fusions in three tumors, two of which had t(6;8) and t(8;15) translocations as the sole anomalies and one a normal karyotype. FISH analyses of interphase nuclei and nuclear chromatin fibers of a fourth adenoma with a normal karyotype revealed that a second fusion partner gene, TCEA1, located about 2 Mb centromeric to PLAG1, also is fused to PLAG1 as a result of a cryptic 8q rearrangement. The breakpoints in both fusions occur in the 5'-noncoding regions of the genes, leading to activation of PLAG1 by promoter swapping/substitution. Western blot and immunohistochemical analyses demonstrated that the PLAG1 protein was overexpressed in epithelial, myoepithelial, and mesenchymal-like tumor cells in tumors with both fusions. Our findings further emphasize the significance of PLAG1 activation in pleomorphic adenomas and demonstrate that the gene is more frequently activated than previously anticipated.
  • Asp, Julia, 1973-, et al. (författare)
  • Nonradioactive in situ hybridization on frozen sections and whole mounts.
  • 2006
  • Ingår i: Methods in molecular biology (Clifton, N.J.). - 1064-3745. ; 326, s. 89-102
  • Tidskriftsartikel (refereegranskat)abstract
    • Nonradioactive in situ hybridization offers a unique opportunity to study gene expression on samples with preserved histological information. This method makes it possible to locate not only where in a tissue a particular gene is expressed, but in many cases also in which specific cell type it is active. Here, we describe our current protocols for in situ hybridization on frozen sections or whole mounts of mouse embryos. The protocols included describe synthesis of a digoxigenin-labeled probe, tissue handling, hybridization of the probe to the mRNA expressed in the sample and signal detection.
  • Persson, Fredrik, 1973-, et al. (författare)
  • High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes
  • 2008
  • Ingår i: Oncogene. - 0950-9232. ; 27:21, s. 3072-3080
  • Tidskriftsartikel (refereegranskat)abstract
    • We have previously identified a subgroup of pleomorphic salivary gland adenomas with ring chromosomes of uncertain derivation. Here, we have used spectral karyotyping (SKY), fluorescence in situ hybridization (FISH) and high-resolution oligonucleotide array-CGH to determine the origin and content of these rings and to identify genes disrupted as a result of ring formation. Of 16 tumors with rings, 11 were derived from chromosome 8, 3 from chromosome 5 and 1 each from chromosomes 1, 6 and 9. Array-CGH revealed that 10/11 r(8) consisted of amplification of a 19 Mb pericentromeric segment with recurrent breakpoints in FGFR1 in 8p12 and in PLAG1 in 8q12.1. Molecular analyses revealed that ring formation consistently generated novel FGFR1-PLAG1 gene fusions in which the 5'-part of FGFR1 is linked to the coding sequence of PLAG1. An alternative mechanism of PLAG1 activation was found in tumors with copy number gain of an intact PLAG1 gene. Rings derived from chromosomes 1, 5, 6 or 9 did not result in gene fusions, but rather resulted in losses indicative of the involvement of putative tumor suppressor genes on 8p, 5p, 5q and/or 6q. Our findings also reveal a novel mechanism by which FGFR1 contributes to oncogenesis and further illustrate the versatility of the FGFR1 and PLAG1 genes in tumorigenesis.
  • Takemoto, Minoru, et al. (författare)
  • Large-scale identification of genes implicated in kidney glomerulus development and function.
  • 2006
  • Ingår i: The EMBO journal. - 0261-4189. ; 25:5, s. 1160-74
  • Tidskriftsartikel (refereegranskat)abstract
    • To advance our understanding of development, function and diseases in the kidney glomerulus, we have established and large-scale sequenced cDNA libraries from mouse glomeruli at different stages of development, resulting in a catalogue of 6053 different genes. The glomerular cDNA clones were arrayed and hybridized against a series of labeled targets from isolated glomeruli, non-glomerular kidney tissue, FACS-sorted podocytes and brain capillaries, which identified over 300 glomerular cell-enriched transcripts, some of which were further sublocalized to podocytes, mesangial cells and juxtaglomerular cells by in situ hybridization. For the earliest podocyte marker identified, Foxc2, knockout mice were used to analyze the role of this protein during glomerular development. We show that Foxc2 controls the expression of a distinct set of podocyte genes involved in podocyte differentiation and glomerular basement membrane maturation. The primary podocyte defects also cause abnormal differentiation and organization of the glomerular vascular cells. We surmise that studies on the other novel glomerulus-enriched transcripts identified in this study will provide new insight into glomerular development and pathomechanisms of disease.
  • Alm, Sofie J., 1988-, et al. (författare)
  • Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
  • 2017
  • Ingår i: International journal of laboratory hematology. - 1751-553X. ; 39:2, s. 121-128
  • Tidskriftsartikel (refereegranskat)abstract
    • The translocation t(12;21)(p13;q22) resulting in the fusion gene ETV6-RUNX1, is the most frequent gene fusion in childhood B lymphoblastic leukemia. In the Nordic Society of Paediatric Haematology and Oncology ALL-2008 treatment protocol, treatment stratification in B-lineage ALL is based on results of minimal residual disease (MRD) analysis with fluorescence-activated cell sorting (FACS). In this study, we determined whether RT-qPCR of the ETV6-RUNX1 fusion transcript can be a reliable alternative for MRD analysis.Seventy-eight bone marrow samples from 29 children at diagnosis and day 15, 29, and 78 during treatment were analyzed for MRD with FACS and with quantitative reverse transcription polymerase chain reaction (RT-qPCR). Fusion transcript MRD was defined as the ETV6-RUNX1/GUSB ratio at the follow-up time point (day 15/29/78) divided with the ETV6-RUNX1/GUSB ratio at diagnosis (%).MRD analysis with FACS and with RT-qPCR of ETV6-RUNX1 fusion transcript showed strong correlation. All cases showed concordant results at the treatment stratifying time points day 29 and day 78, when comparing the two methods with a cutoff set to 0.1%.RT-qPCR is a valuable addition and could also be an alternative to FACS in cases where FACS is not achievable for MRD analysis.
  • Andersson, Henrik, et al. (författare)
  • Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
  • 2010
  • Ingår i: Journal of biotechnology. - 1873-4863. ; 150:1, s. 175-81
  • Tidskriftsartikel (refereegranskat)abstract
    • Human embryonic stem cell (hESC) derived cardiomyocytes are in the present study being used for testing drug-induced cardiotoxicity in a biosensor set-up. The design of an in vitro testing alternative provides a novel opportunity to surpass previous methods based on rodent cells or cell lines due to its significantly higher toxicological relevance. In this report we demonstrate how hESC-derived cardiomyocytes release detectable levels of two clinically decisive cardiac biomarkers, cardiac troponin T and fatty acid binding protein 3, when the cardiac cells are exposed to the well-known cardioactive drug compound, doxorubicin. The release is monitored by the immuno-biosensor technique surface plasmon resonance, particularly appropriate due to its capacity for parallel and high-throughput analysis in complex media.
  • Andreasson, B., et al. (författare)
  • ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients
  • 2020
  • Ingår i: British Journal of Haematology. - 0007-1048. ; 189:5, s. 913-919
  • Tidskriftsartikel (refereegranskat)abstract
    • Polycythaemia vera (PV) patients have an overall comparatively favourable prognosis, but disease progression is very heterogeneous and life-threatening thrombosis and bleedings are frequent complications in untreated disease. Moreover, transformation to more severe secondary myelofibrosis and acute myeloid leukaemia can occur. The aim of this study was to identify gene mutations that could be used together with clinical data as prognostic markers to guide treatment decisions in PV patients. A well-characterized WHO-defined cohort of PV patients was used. Clinical data and blood values were evaluated and a myeloid sequencing panel was used to screen for additional mutations other than the diagnostic JAK2 V617F and JAK2 exon 12 mutations. In 78% of the PV patients, at least one mutation additional to JAK2 V617F was detected. Additional mutations in genes coding for epigenetic modifiers, like TET2, DNMT3A and ASXL1, were most frequent. When correlated to overall survival, mutations in ASXL1 were significantly associated with inferior survival. In an attempt to obtain prognostic guidance in a larger number of patients, the presence of ASXL1 mutations was combined with age and vascular complications prior to diagnosis. Based on these data we were able to define three risk groups that predicted survival.
  • Asp, Julia, 1973-, et al. (författare)
  • Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
  • 2001
  • Ingår i: Journal of orthopaedic research : official publication of the Orthopaedic Research Society. - 0736-0266. ; 19:1, s. 149-54
  • Tidskriftsartikel (refereegranskat)abstract
    • The G1 regulatory pathway involving p16, pRb and cdk4 in the cell cycle has been investigated in human chondrosarcoma. The protein expression of p16, pRb and cdk4 was analyzed by Western blot in cultured cells from eight chondrosarcomas and in two chondrosarcoma cell lines. Both cell lines and one other sample were negative for p16. Moreover, one of the cell lines was pRb-negative and showed a high expression of cdk4 as well. In the other cell line and in three other samples pRb of expected size were detected in addition to a shorter form of the protein. To further investigate the reasons for down-regulation of the p16 protein, the p16-coding gene CDKN2 was analyzed by polymerase chain reaction (PCR), methyl-specific PCR (MSP) and sequencing in all tumor samples as well as in corresponding tumor tissues from three of the samples. The p16-negative samples were all found to have homozygous deletion of CDKN2. Another sample showed partial gene methylation and a heterozygous position in codon 148 was detected in one sample. The same base substitution was also found in two of the tissue samples. Finally, cytogenetic analysis of the samples with homozygously deleted CDKN2 revealed multiple structural abnormalities in all three cases. In conclusion, the p16/pRb/cdk4 pathway may play an important role in the pathogenesis of some chondrosarcomas.
  • Asp, Julia, 1973-, et al. (författare)
  • Cardiomyocyte clusters derived from human embryonic stem cells share similarities with human heart tissue.
  • 2010
  • Ingår i: Journal of molecular cell biology. - 1759-4685. ; 2:5, s. 276-83
  • Tidskriftsartikel (refereegranskat)abstract
    • Cardiotoxicity testing is a key activity in the pharmaceutical industry in order to detect detrimental effects of new drugs. A reliable human in vitro model would both be beneficial in selection of lead compounds and be important for reducing animal experimentation. However, the human heart is a complex organ composed of many distinct types of cardiomyocytes, but cardiomyocyte clusters (CMCs) derived from human embryonic stem cells could be an option for a cellular model. Data on functional properties of CMCs demonstrate similarities to their in vivo analogues in human. However, development of an in vitro model requires a more thorough comparison of CMCs to human heart tissue. Therefore, we directly compared individually isolated CMCs to human fetal, neonatal, adult atrial and ventricular heart tissues. Real-time qPCR analysis of mRNA levels and protein staining of ion channels and cardiac markers showed in general a similar expression pattern in CMCs and human heart. Moreover, a significant decrease in beat frequency was noted after addition of Zatebradine, a blocker to I(f) involved in regulation of spontaneous contraction in CMCs. The results underscore the similarities of CMCs to human cardiac tissue, and further support establishment of novel cardiotoxicity assays based on the CMCs in drug discovery.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 38
  • [1]234Nästa
fritt online (3)
Typ av publikation
tidskriftsartikel (34)
forskningsöversikt (2)
konferensbidrag (1)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (36)
övrigt vetenskapligt (2)
Asp, Julia, 1973-, (38)
Lindahl, Anders, 195 ... (19)
Jeppsson, Anders, 19 ... (11)
Palmqvist, Lars, 196 ... (10)
Fogelstrand, Linda, ... (4)
Abrahamsson, Jonas, ... (3)
visa fler...
Samuelsson, Tore, 19 ... (3)
Alm, Sofie J., 1988- ... (3)
Stenman, Göran, 1953 ... (3)
Sartipy, Peter (3)
Steel, Daniella, (3)
Betsholtz, C, (2)
Betsholtz, Christer, ... (2)
Persson, Fredrik, 19 ... (2)
Dahlenborg, Kerstin, (2)
Pettersson, H (1)
Mostad, Petter, 1964 ... (1)
Abramsson, A (1)
Alitalo, K (1)
Alitalo, Kari (1)
Kristiansson, Erik, ... (1)
Johansson, P. (1)
Andersson, Henrik (1)
Andreasson, B (1)
Abelsson, Johanna (1)
Lenhoff, Stig, (1)
Andréasson, Björn, (1)
Abramsson, Alexandra ... (1)
Tryggvason, K, (1)
Esteller, Manel (1)
Lundin, Samuel B, 19 ... (1)
Lundqvist, Annika, 1 ... (1)
Lundin, S (1)
Donnes, P (1)
Brune, Mats, 1950-, (1)
Holgersson, Jan, (1)
Jeppsson, A (1)
Meyer, Thomas, (1)
Kjaer, Lasse (1)
Ehinger, Mats, (1)
Kost-Alimova, M, (1)
Persson, F., (1)
Engvall, C (1)
Engvall, Charlotte (1)
Améen, Caroline, 197 ... (1)
He, Liqun, (1)
McMullin, Mary F. (1)
Leibundgut, Elisabet ... (1)
Enlund, Fredrik, 196 ... (1)
Kågedal, Bertil, (1)
visa färre...
Göteborgs universitet (38)
Karolinska Institutet (3)
Chalmers tekniska högskola (2)
Lunds universitet (1)
Engelska (38)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (37)
Naturvetenskap (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy